The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Molecular Diagnosis and Therapy Market Research Report 2025

Global Molecular Diagnosis and Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1899539

No of Pages : 86

Ask Your Query
Synopsis
Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.
The global Molecular Diagnosis and Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnosis and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnosis and Therapy.
Report Scope
The Molecular Diagnosis and Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnosis and Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnosis and Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Biomérieux Sa
Danaher Corporation
Diasorin
Grifols
Hologic
Illumina
Qiagen
Roche Diagnostics
Siemens AG
Thermo Fisher Scientific
Segment by Type
PCR
DNA Sequencing
NGS
Segment by Application
Diagnostic Laboratories
Research & Academic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnosis and Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 DNA Sequencing
1.2.4 NGS
1.3 Market by Application
1.3.1 Global Molecular Diagnosis and Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Laboratories
1.3.3 Research & Academic Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnosis and Therapy Market Perspective (2019-2030)
2.2 Molecular Diagnosis and Therapy Growth Trends by Region
2.2.1 Global Molecular Diagnosis and Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Diagnosis and Therapy Historic Market Size by Region (2019-2024)
2.2.3 Molecular Diagnosis and Therapy Forecasted Market Size by Region (2025-2030)
2.3 Molecular Diagnosis and Therapy Market Dynamics
2.3.1 Molecular Diagnosis and Therapy Industry Trends
2.3.2 Molecular Diagnosis and Therapy Market Drivers
2.3.3 Molecular Diagnosis and Therapy Market Challenges
2.3.4 Molecular Diagnosis and Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnosis and Therapy Players by Revenue
3.1.1 Global Top Molecular Diagnosis and Therapy Players by Revenue (2019-2024)
3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnosis and Therapy Revenue
3.4 Global Molecular Diagnosis and Therapy Market Concentration Ratio
3.4.1 Global Molecular Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis and Therapy Revenue in 2023
3.5 Molecular Diagnosis and Therapy Key Players Head office and Area Served
3.6 Key Players Molecular Diagnosis and Therapy Product Solution and Service
3.7 Date of Enter into Molecular Diagnosis and Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnosis and Therapy Breakdown Data by Type
4.1 Global Molecular Diagnosis and Therapy Historic Market Size by Type (2019-2024)
4.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2025-2030)
5 Molecular Diagnosis and Therapy Breakdown Data by Application
5.1 Global Molecular Diagnosis and Therapy Historic Market Size by Application (2019-2024)
5.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Molecular Diagnosis and Therapy Market Size (2019-2030)
6.2 North America Molecular Diagnosis and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Molecular Diagnosis and Therapy Market Size by Country (2019-2024)
6.4 North America Molecular Diagnosis and Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnosis and Therapy Market Size (2019-2030)
7.2 Europe Molecular Diagnosis and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Molecular Diagnosis and Therapy Market Size by Country (2019-2024)
7.4 Europe Molecular Diagnosis and Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnosis and Therapy Market Size (2019-2030)
8.2 Asia-Pacific Molecular Diagnosis and Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnosis and Therapy Market Size (2019-2030)
9.2 Latin America Molecular Diagnosis and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Molecular Diagnosis and Therapy Market Size by Country (2019-2024)
9.4 Latin America Molecular Diagnosis and Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnosis and Therapy Market Size (2019-2030)
10.2 Middle East & Africa Molecular Diagnosis and Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Molecular Diagnosis and Therapy Introduction
11.2.4 Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.2.5 Agilent Technologies Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Detail
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Introduction
11.3.4 Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 Biomérieux Sa
11.4.1 Biomérieux Sa Company Detail
11.4.2 Biomérieux Sa Business Overview
11.4.3 Biomérieux Sa Molecular Diagnosis and Therapy Introduction
11.4.4 Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.4.5 Biomérieux Sa Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Detail
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Molecular Diagnosis and Therapy Introduction
11.5.4 Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.5.5 Danaher Corporation Recent Development
11.6 Diasorin
11.6.1 Diasorin Company Detail
11.6.2 Diasorin Business Overview
11.6.3 Diasorin Molecular Diagnosis and Therapy Introduction
11.6.4 Diasorin Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.6.5 Diasorin Recent Development
11.7 Grifols
11.7.1 Grifols Company Detail
11.7.2 Grifols Business Overview
11.7.3 Grifols Molecular Diagnosis and Therapy Introduction
11.7.4 Grifols Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.7.5 Grifols Recent Development
11.8 Hologic
11.8.1 Hologic Company Detail
11.8.2 Hologic Business Overview
11.8.3 Hologic Molecular Diagnosis and Therapy Introduction
11.8.4 Hologic Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.8.5 Hologic Recent Development
11.9 Illumina
11.9.1 Illumina Company Detail
11.9.2 Illumina Business Overview
11.9.3 Illumina Molecular Diagnosis and Therapy Introduction
11.9.4 Illumina Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.9.5 Illumina Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnosis and Therapy Introduction
11.10.4 Qiagen Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.10.5 Qiagen Recent Development
11.11 Roche Diagnostics
11.11.1 Roche Diagnostics Company Detail
11.11.2 Roche Diagnostics Business Overview
11.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Introduction
11.11.4 Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.11.5 Roche Diagnostics Recent Development
11.12 Siemens AG
11.12.1 Siemens AG Company Detail
11.12.2 Siemens AG Business Overview
11.12.3 Siemens AG Molecular Diagnosis and Therapy Introduction
11.12.4 Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.12.5 Siemens AG Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Detail
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Introduction
11.13.4 Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2019-2024)
11.13.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock